Pretreatment Lipoprotein(a) as a Biomarker for EGFR Mutation and Prognosis in Lung Adenocarcinoma
International Journal of General Medicine · 2024-12 · Volume 17 · 6465-6478
DOI: 10.2147/ijgm.s501401 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of General Medicine, 2024-12. Verfasst von Ji Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People's Rep…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People's Republic of China.
- Rheumatology and Immunology department, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, People's Republic of China.
- Department of Geriatrics, the First People's Hospital of Jiashan County, Jiaxing, Zhejiang Province, People's Republic of China.
Zitieren
APA
Liu, J., Liu, Z., Xu, D., Zhou, T., Li, A., Hu, J., Li, H., Li, W., Wang, Z., Yu, Z., & Zeng, L. (2024). Pretreatment Lipoprotein(a) as a Biomarker for EGFR Mutation and Prognosis in Lung Adenocarcinoma. International Journal of General Medicine, Volume 17, 6465-6478. https://doi.org/10.2147/ijgm.s501401
Vancouver
Liu J, Liu Z, Xu D, Zhou T, Li A, Hu J, et al. Pretreatment Lipoprotein(a) as a Biomarker for EGFR Mutation and Prognosis in Lung Adenocarcinoma. International Journal of General Medicine. 2024;Volume 17:6465-6478. doi:10.2147/ijgm.s501401
BibTeX
@article{Liu2024,
author = {Liu, Ji and Liu, Zhekang and Xu, Deming and Zhou, Tao and Li, Ang and Hu, Jiali and Li, Hong and Li, Wenjie and Wang, Zengqing and Yu, Zhiping and Zeng, Linxiang},
title = {Pretreatment Lipoprotein(a) as a Biomarker for EGFR Mutation and Prognosis in Lung Adenocarcinoma},
journal = {International Journal of General Medicine},
year = {2024},
volume = {Volume 17},
pages = {6465--6478},
doi = {10.2147/ijgm.s501401}
}
EUVIMED